Aegerion Pharmaceuticals, Inc. (AEGR) Announces Fourth-Quarter and Year-End 2012 Financial Results  
3/6/2013 11:14:42 AM

CAMBRIDGE, Mass., March 6, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal rare diseases, announced its financial results and business highlights for the fourth-quarter and year-ended December 31, 2012.